HopeStage
Back to all studies
WithdrawnNCT01372722

Deep Brain Stimulation (DBS) for Treatment Resistant Bipolarity

Device studyAges 20–70Germany
The study in practice

Understand this study

Who could participate?

Listed age limits: 20 years to 70 years.

Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 2010
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
University Hospital, Bonn
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
DEVICE
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
Germany
Age range
From 20 Years to 70 Years
Official registry ID
NCT01372722
Official title
Show the full official title

Phase I Study of Bilateral DBS to the Nucleus Accumbens (NAcc-DBS) for Treatment Resistant Bipolar Disorder

Recruitment & locations

Withdrawn

Bonn

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University Hospital, Bonn, a hospital or academic medical center.

Who can participate?

Listed age limits: 20 years to 70 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies